摘要
胃癌是我国最常见的恶性肿瘤之一,病死率高。胃癌病人诊断时多已处晚期,进展期胃癌超过90%,根治术后5年存活率为30%~50%,复发和转移是预后不良的首因。与大肠癌等其他消化道肿瘤相比,进展期胃癌治疗的进步稍显缓慢。
出处
《中国实用外科杂志》
CSCD
北大核心
2011年第8期723-725,共3页
Chinese Journal of Practical Surgery
关键词
胃癌
放射治疗
gastric cancer
radiotherapy
参考文献17
-
1胡广原,魏瑶,梅齐,胡国清.进展期胃癌术后同步放化疗32例的回顾分析[J].中国临床医学,2009,16(4):553-555. 被引量:9
-
2Huan-Long Qin Chao-Hong Lin Xiu-Long Zhang.Evaluation of intraoperative radiotherapy for gastric carcinoma with D2 and D3 surgical resection[J].World Journal of Gastroenterology,2006,12(43):7033-7037. 被引量:9
-
3陈东福等著,殷蔚伯,谷铣之.肿瘤放射治疗学[M]中国协和医科大学出版社,2002.
-
4Zhang ZX,Gu XZ,Yin WB,et al.Randomized clinical trial on the combination of preoperative irradiation and surgery in the treatment of adenocarcinoma of gastric cardia(AGC)--report on370patients. International Journal of Radiation Oncology Biology Physics . 1998
-
5Stahl M,Walz MK,Stuschke M,et al.Phase III comparison of preoperative chemotherapy compared with chemoradiotherapy in patients with locally advanced adenocarcinoma of the esophagogastric junction. Journal of Clinical Oncology . 2009
-
6V. Valentini,F. Cellini,B.D. Minsky.Survival after radiotherapy in gastric cancer: systematic review and meta-analysis. Radiotherapy and Oncology . 2009
-
7O. Matzinger,E. Gerber,Z. Bernstein.EORTC-ROG expert opinion: radiotherapy volume and treatment guidelines for neoadjuvant radiation of adenocarcinomas of the gastroesophageal junction and the stomach. Radiotherapy and Oncology . 2009
-
8Okines A,Verheij M,Allum W,ESMO Guidelines Working Group et al.Gastric cancer:ESMO Clinical Practice Guidelines for diagnosis,treatment and follow-up. Annals of Oncology . 2010
-
9Lim DH,,Kim DY,Kang MK,et al.Patterns of failure ingastric carcinoma after D2 gastrectomy and chemoradiothera-py:A radiation oncologist s view. British Journal of Cancer . 2004
-
10Kim S,,Lim do H,Lee J,et al.An observational studysuggesting clinical benefit for adjuvant postoperative chemora-diation in a population of over500 cases after gastric resectionwith D2 nodal dissection for adenocarcinoma of the stomach. International Journal of Radiation Oncology Biology Physics . 2005
二级参考文献26
-
1Hundahl SA, Macdonald JS, Benedetti J, et al. Surgical treatment variation in a prospective, randomized trial of chemoradiotherapy in gastric cancer: the effect of undertreatment[J]. Annals of surgical ontology, 2002,9(3) :278-286.
-
2Smalley SR, Gunderson L, Tepper J, et al. Gastric surgical adjuvant radiotherapy consensus report: rationale and treatment implementation[J]. International Journal of Radiation Oncology, Biology, Physics, 2002,52(2):283-293.
-
3Macdonald JS, Smalley SR, Benedetti J, et al. Chemoradiotherapy after surgery compared with surgery alone for adenocareino ma of the stomach or gastroesophageal junetlon[J] The New England Journal of Medielne, 2001,345(10):725-730.
-
4Tsujinaka T, Fujitani K, Hirao M, et al. Current status of chemoradiotherapy for gastric cancer in Japan[J]. International Journal of Clinical Oncology/Japan Society of Clinical Oncology, 2008,13(2) : 117-120.
-
5Mawdsley S, Glynne Jones R, Grainger J, et al. Can histopathologic assessment of circumferential margin after preoperative pelvic chemoradiotherapy for T3-T4 rectal cancer predict for 3-year disease-free survival? [J]. International Journal of Radiation Oncology, Biology, Ohysics, 2005,63(3):745-752.
-
6Garrido M, Bustos M, Orellana E, et al. Postoperative radiochemotherapy in locally advanced gastric cancer[J]. Rev Med Chil, 2008,136(7):844-850.
-
7Sano T. Adjuvant and neoadjuvant therapy of gastric cancer:a comparison of three pivotal studies[J]. Curr Oncol Rep, 2008, 10(3):191-198.
-
8[1]Cuschieri A,Weeden S,Fielding J,Bancewicz J,Craven J,Joypaul V,Sydes M,Fayers P.Patient survival after D1 and D2 resections for gastric cancer:long-term results of the MRC randomized surgical trial.Surgical Co-operative Group.Br J Cancer 1999; 79:1522-1530
-
9[2]Coquard R,Ayzac L,Gilly FN,Rocher FP,Romestaing P,Sentenac I,Francois Y,Vignal J,Braillon G,Gerard JP.Intraoperative radiation therapy combined with limited lymph node resection in gastric cancer:an alternative to extended dissection? Int J Radiat Oncol Biol Phys 1997; 39:1093-108
-
10[3]Minsky BD.The role of radiation therapy in gastric cancer.Semin Oncol 1996; 23:390-396
共引文献16
-
1王志海,荆航.局部进展期胃癌根治术后同期放化疗与单纯化疗的临床对比观察[J].医学信息(医学与计算机应用),2014,0(9):419-419.
-
2杨正强,于甬华.放射治疗在胃癌综合治疗中的意义[J].中国肿瘤,2010,19(7):465-469. 被引量:4
-
3李桂超,章真.胃癌术中放疗的应用及进展[J].中华放射肿瘤学杂志,2010,19(5):462-464. 被引量:3
-
4涂向阳.局部晚期胃癌术后同步放化疗临床研究[J].实用肿瘤杂志,2011,26(1):62-64. 被引量:10
-
5刘峥,尹继磊,张振军,张林平.放射治疗在胃癌辅助治疗中的作用[J].河北医药,2011,33(5):752-755. 被引量:1
-
6霍丹,张小丽,马玉芳,王继红.同步放化疗联合复方苦参注射液治疗Ⅲ期胃癌术后临床观察[J].中国医院用药评价与分析,2011,11(8):727-730. 被引量:2
-
7鞠芳,杨晓慧,陈洁.106例胃癌术后不同放疗方式的疗效比较研究[J].中国医药指南,2012,10(10):489-490. 被引量:2
-
8林展,严浩林,朱海生,梁雷锋,伍伦庆,侯国松.化疗联合同步放疗治疗胃癌生活质量观察[J].中国医学创新,2012,9(25):103-104. 被引量:3
-
9王晓雷.胃癌的治疗进展[J].医学理论与实践,2012,25(22):2758-2761. 被引量:2
-
10张永康,杨林.局部进展期胃癌的治疗进展[J].安徽医科大学学报,2013,48(8):992-994. 被引量:9
同被引文献90
-
1沈琳.胃癌综合治疗临床问题与药物治疗新视角[J].中国医学前沿杂志(电子版),2012,4(5):1-3. 被引量:5
-
2Lei Chen,Ming-Quan Song,Hui-Zhong Lin,Lin-Hua Hao,Xiang-Jun Jiang,Zi-Yu Li,Yu-Xin Chen.Chemotherapy and resection for gastric cancer with synchronous liver metastases[J].World Journal of Gastroenterology,2013,19(13):2097-2103. 被引量:19
-
3刘小南,霍婷婷,王为忠,管文贤.参附注射液对大鼠胰腺移植受体小肠肠粘膜屏障的保护作用[J].消化外科,2005,4(5):341-345. 被引量:3
-
4张仁岭,张胜华,冯寿全.四君子汤加味对胃肠道手术后肠粘膜屏障功能的作用[J].中国中西医结合外科杂志,2006,12(1):6-9. 被引量:49
-
5张仁岭,张胜华,冯寿全.四君子汤加大黄对脓毒症大鼠肠黏膜屏障功能的保护作用[J].中国中西医结合消化杂志,2006,14(3):160-163. 被引量:24
-
6李智强.FOLFOX4方案辅助化疗中晚期胃癌24例临床观察[J].实用肿瘤学杂志,2006,20(4):323-323. 被引量:2
-
7杜义安,季永领,程向东.可手术胃癌综合治疗进展[J].中国肿瘤,2007,16(5):331-334. 被引量:4
-
8Hur H, Kim SH, Kim W, et al. The efficacy of preoperative PET/CT for prediction of curability in surgery for locally ad- vanced gastric carcinoma[J]. World J Surg Oncol,2010,10 (8) :86.
-
9Oda I,Gotoda T, Hamanaka H,et al. Endoscopic submuco- sal dissection for early gastric cancer:technical feasibility, operation time and complications from a large consecutive series [J]. Dig Endosc ,2005,17 ( 1 ) :54 - 58.
-
10Sierra A, Regueira FM, Hemandez - Lizoain JL, et al. Role of the extended lymphadenectomy in gastric cancer surgery: experience in a single ins Titution [J]. Ann Surg Oncol, 2003,10(3) :219 -226.
引证文献6
-
1刘雪峰(综述),吕洪光(审校).胃癌的综合治疗[J].实用肿瘤学杂志,2012,26(3):268-271. 被引量:15
-
2邓皖利,吕书勤,任小娟,王昕宇,王巧琳,陆明.益气复生方对胃癌原位移植瘤小鼠肠黏膜屏障的影响[J].世界华人消化杂志,2013,21(11):951-956. 被引量:9
-
3张信强,徐燕,陈明祥.替吉奥胶囊单药联合放疗治疗晚期胃癌的临床观察[J].临床肿瘤学杂志,2013,18(7):628-630. 被引量:14
-
4万源,戴建国.晚期胃癌的西医治疗进展[J].中医学报,2013,28(B08):433-433.
-
5张琰君,郭娟,于得全,齐宇红,邵秋菊,常浩,梁军.68例高龄中晚期胃癌姑息性三维适形放疗结果分析[J].现代肿瘤医学,2014,22(3):603-606. 被引量:12
-
6黄秀钦.中国放射治疗文献统计分析[J].现代肿瘤医学,2017,25(23):3855-3858.
二级引证文献48
-
1杨炎,王正兵.胃癌根治术后手术部位感染相关因素的研究进展[J].世界临床医学,2019,13(2):60-61. 被引量:1
-
2张成刚,冯寿全,孙久运,李兆基,赵震宇,顾群浩,张胜华.术中腹腔灌注热化疗治疗进展期胃肠道肿瘤的安全性研究[J].中国肿瘤外科杂志,2013,5(2):91-94. 被引量:9
-
3张洪峰,章艳,苏慧.蝙蝠葛酚性碱对胃癌细胞SGC-7901增殖作用的实验研究[J].实用肿瘤学杂志,2013,27(2):116-119. 被引量:3
-
4李光忠,蔺国祥,孙长寿.糖尿病并发肺结核外周血可溶性Fas和可溶性FasL水平研究[J].中国医师进修杂志,2013,36(13):8-11. 被引量:5
-
5刘军.DCF方案与ECF方案治疗进展期胃癌的临床研究[J].中国医师进修杂志,2013,36(17):17-19. 被引量:6
-
6梁林虎,陈贤军,左学良.个体化原则在胃癌合并门静脉高压症治疗中的应用[J].蚌埠医学院学报,2013,38(9):1111-1113.
-
7周伟,牛文柯,屠春雨,徐文英.胃癌根除术同步放化疗患者的生活质量及影响因素研究[J].浙江预防医学,2014,26(1):37-40. 被引量:7
-
8胡建国,王保国,王兵.胃癌术后患者手术切口感染的危险因素分析[J].中华医院感染学杂志,2014,24(1):151-153. 被引量:10
-
9张锡(综述),薛英威(审校).胃癌Her-2的表达与靶向治疗[J].实用肿瘤学杂志,2014,28(2):177-181. 被引量:9
-
10赵彦波,杨岩.替吉奥胶囊联合同步放疗治疗晚期胃癌的临床效果[J].中国药物经济学,2018,13(12):92-94.
-
1马路,李成继,彭学锋.创伤性窒息65例的诊断和治疗[J].深圳中西医结合杂志,2005,15(4):230-231.
-
2杨佳勇,杨振九,冯承宣,李宏伟,李维平,张浚,张洪.169例脑弥漫性轴索损伤的诊断和预后分析[J].中华神经医学杂志,2005,4(8):835-836. 被引量:8
-
3李秋成,王晓春,蔡端,张延玲.重症急性胆管炎手术时机选择及围手术期并发症(附142例分析)[J].黑龙江医学,2002,26(5):332-333. 被引量:2
-
4李秋成,赵金芝.重症急性胆管炎142例分析治疗体会[J].中国医药指南,2008,6(15):147-148. 被引量:3
-
5邹琴,廖湘平,郭胜根.胱抑素C在造影剂肾病早期诊断中的价值[J].医学临床研究,2011,28(12):2379-2381. 被引量:7
-
6冯隐微.诊断性腹腔穿刺术在急腹症中的应用——附105例分析[J].哈尔滨医药,1994,14(1).
-
7李惊子.尿液分析在肾脏疾病诊断中的重要性[J].中国中西医结合肾病杂志,2005,6(3):125-128. 被引量:5
-
8李忠祥,李清喜,熊绍勇.外伤性小肠破裂112例诊治体会[J].实用预防医学,2004,11(3):540-541.
-
9詹瑞森,黄贤炎,杨辉芳,李小如.股骨头缺血性坏死的CT诊断及手术抉择[J].湖南医学,2000,17(4):244-246.
-
10张克非,史峰军,宋银冬,沈建辉,林博川.经后腹膜减压治疗骨盆骨折所致腹腔间隔室综合征[J].中国伤残医学,2013,21(8):17-19. 被引量:1